May 15, 2025 07:30AM
May 7, 2025 06:30AM
May 6, 2025 07:00AM
Apr 29, 2025 06:30AM
Apr 10, 2025 07:30AM
Apr 10, 2025 07:30AM
Mar 31, 2025 07:00AM BrainStorm Cell Therapeutics Announces Full Year 2024 Financial Results and Provides Corporate Update
Dec 30, 2024 08:00AM
Dec 30, 2024 08:00AM
Nov 11, 2024 06:00AM
Oct 28, 2024 06:00AM
Oct 7, 2024 07:00AM
Sep 24, 2024 06:00AM
Aug 14, 2024 07:05AM BrainStorm Cell Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update
Jun 26, 2024 08:02AM
Jun 26, 2024 08:00AM
May 20, 2024 06:00AM
May 14, 2024 04:30PM
Apr 17, 2024 05:42AM
Apr 16, 2024 06:30PM
Apr 10, 2024 06:01AM Brainstorm Cell Therapeutics (BCLI) Announces Peer-reviewed Publication of Biomarker Data from NurOwn's® Phase 3 Clinical Trial in ALS
Apr 10, 2024 06:00AM
Apr 9, 2024 06:01AM
Apr 9, 2024 06:00AM
Apr 8, 2024 06:00AM
Apr 1, 2024 08:05AM
Feb 27, 2024 06:32AM
Feb 27, 2024 06:30AM BrainStorm Cell Therapeutics to Unveil Phase 3b NurOwn® Trial Design at MDA Clinical and Scientific Conference
Feb 23, 2024 06:00AM
Feb 23, 2024 06:00AM
Feb 13, 2024 06:30AM
Dec 26, 2023 07:30AM
Dec 26, 2023 07:30AM
Dec 20, 2023 09:01AM
Dec 20, 2023 09:00AM BrainStorm Issues 2023 Letter to Shareholders
Dec 7, 2023 08:40AM
Dec 7, 2023 08:40AM
Nov 14, 2023 07:05AM
Sep 28, 2023 05:20AM
Sep 27, 2023 10:48PM
Sep 27, 2023 07:01AM
Sep 27, 2023 07:00AM BrainStorm Cell Therapeutics Stock Trading Halted Today
Aug 14, 2023 07:05AM
Jul 12, 2023 07:02AM
Jul 12, 2023 07:00AM
Jul 7, 2023 07:04AM
Jul 7, 2023 07:03AM
Jun 6, 2023 06:02AM
Jun 6, 2023 06:00AM BrainStorm Cell Therapeutics Announces FDA Advisory Committee Meeting to Review NurOwn® Biologics License Application Scheduled for September 27, 2023
May 19, 2023 07:30AM

15,627 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All